Skip to main content

News

children
News
05/28/2025
Riya Gandhi, MA
A long-term study shows that dupilumab significantly reduces asthma exacerbations in children with type 2 asthma, offering sustained benefits for both allergic and non-allergic patients.
A long-term study shows that dupilumab significantly reduces asthma exacerbations in children with type 2 asthma, offering sustained benefits for both allergic and non-allergic patients.
A long-term study shows that...
05/28/2025
The Derm APP
News
05/13/2025
Lisa Kuhns, PhD, MD
First-line (1L) treatment with immune checkpoint inhibitors (ICIs), particularly in combination with chemotherapy, is the most frequently used and costliest systemic therapy for metastatic non-small cell lung cancer (NSCLC) patients without...
First-line (1L) treatment with immune checkpoint inhibitors (ICIs), particularly in combination with chemotherapy, is the most frequently used and costliest systemic therapy for metastatic non-small cell lung cancer (NSCLC) patients without...
First-line (1L) treatment with...
05/13/2025
First Report Managed Care
Atopic Dermatitis + Baby + Face
News
10/17/2023
Riya Gandhi, MA
A recent study published in the Journal of Allergy and Clinical Immunology discovered that enhanced early skin treatment can substantially reduce the risk of developing food allergies in infants with atopic dermatitis.
A recent study published in the Journal of Allergy and Clinical Immunology discovered that enhanced early skin treatment can substantially reduce the risk of developing food allergies in infants with atopic dermatitis.
A recent study published in the...
10/17/2023
The Dermatologist
laptop with stethoscope
News
06/08/2023
Jolynn Tumolo
Combining electronic health record data such as laboratory tests, radiological orders, and medications provides improved detection of primary immunodeficiency disease, research shows.
Combining electronic health record data such as laboratory tests, radiological orders, and medications provides improved detection of primary immunodeficiency disease, research shows.
Combining electronic health...
06/08/2023
Rheumatology & Arthritis
News
12/01/2022
Jolynn Tumolo
A post hoc analysis showed long-term treatment with a systemic therapy option was efficacious and safe in patients with asthma who had coexisting chronic rhinosinusitis and/or nasal polyps.
A post hoc analysis showed long-term treatment with a systemic therapy option was efficacious and safe in patients with asthma who had coexisting chronic rhinosinusitis and/or nasal polyps.
A post hoc analysis showed...
12/01/2022
First Report Managed Care
Insights from ACAAI 2022
11/30/2022
Theresa A. Bingemann, MD
In this video, Theresa Bingemann, MD, reviews recent literature about early-introduction foods to prevent food allergy, some of the most common food allergies, and outgrowing food allergies. Dr Bingemann also spoke about these topics during...
In this video, Theresa Bingemann, MD, reviews recent literature about early-introduction foods to prevent food allergy, some of the most common food allergies, and outgrowing food allergies. Dr Bingemann also spoke about these topics during...
In this video, Theresa...
11/30/2022
Allergy & Immunology
News
07/07/2022
Jolynn Tumolo
Buzzagogo Inc is voluntarily recalling a nasal swab used to lessen seasonal allergy symptoms due to contamination concerns.
Buzzagogo Inc is voluntarily recalling a nasal swab used to lessen seasonal allergy symptoms due to contamination concerns.
Buzzagogo Inc is voluntarily...
07/07/2022
Pharmacy Learning Network
News
06/14/2022
Jessica Garlewicz
According to a study, atopic dermatitis (AD) mediates the interleukin-4 receptor alpha chain gene variant and food allergy association in school-aged children.
According to a study, atopic dermatitis (AD) mediates the interleukin-4 receptor alpha chain gene variant and food allergy association in school-aged children.
According to a study, atopic...
06/14/2022
The Dermatologist
News
01/27/2022
Jolynn Tumolo
Class III recalls have been issued for allergy medications that failed to meet dissolution specifications. 
Class III recalls have been issued for allergy medications that failed to meet dissolution specifications. 
Class III recalls have been...
01/27/2022
Pharmacy Learning Network
News
11/05/2021
Jolynn Tumolo
A voluntary recall has been issued for an over-the-counter antihistamine used to treat seasonal allergies.
A voluntary recall has been issued for an over-the-counter antihistamine used to treat seasonal allergies.
A voluntary recall has been...
11/05/2021
Pharmacy Learning Network